The PI3K‐Akt signaling pathway, concretely explained as the phosphatidylinositol 3‐kinase (PI3K)/AKT/mammalian target of the rapamycin (mTOR) signaling pathway, is aberrant in many types of cancer 60, 61, 62, 63. This evidence concerns the gene PIK3CD and cancer.